181 related articles for article (PubMed ID: 33019717)
1. Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways.
Ozfiliz Kilbas P; Sonmez O; Uysal-Onganer P; Coker Gurkan A; Obakan Yerlikaya P; Arisan ED
Biology (Basel); 2020 Oct; 9(10):. PubMed ID: 33019717
[TBL] [Abstract][Full Text] [Related]
2. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
5. Bag-1 silencing enhanced chemotherapeutic drug-induced apoptosis in MCF-7 breast cancer cells affecting PI3K/Akt/mTOR and MAPK signaling pathways.
Kilbas PO; Akcay IM; Doganay GD; Arisan ED
Mol Biol Rep; 2019 Feb; 46(1):847-860. PubMed ID: 30661182
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel induces apoptosis through the TAK1-JNK activation pathway.
Yu-Wei D; Li ZS; Xiong SM; Huang G; Luo YF; Huo TY; Zhou MH; Zheng YW
FEBS Open Bio; 2020 Aug; 10(8):1655-1667. PubMed ID: 32594651
[TBL] [Abstract][Full Text] [Related]
7. SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.
Zhang W; Zheng X; Meng T; You H; Dong Y; Xing J; Chen S
J Drug Target; 2017 Mar; 25(3):255-263. PubMed ID: 27718638
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
Li G; Xu D; Sun J; Zhao S; Zheng D
Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
[TBL] [Abstract][Full Text] [Related]
9. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
[TBL] [Abstract][Full Text] [Related]
10. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.
Chen D; Lin X; Zhang C; Liu Z; Chen Z; Li Z; Wang J; Li B; Hu Y; Dong B; Shen L; Ji J; Gao J; Zhang X
Cell Death Dis; 2018 Jan; 9(2):123. PubMed ID: 29374144
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
12. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.
Chen J; Sun WL; Wasylyk B; Wang YP; Zheng H
Anticancer Drugs; 2012 Jan; 23(1):98-107. PubMed ID: 21968419
[TBL] [Abstract][Full Text] [Related]
14. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
15. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
16. [Quercetin induces apoptosis of human breast cancer cells by activiting PTEN and inhibiting PI3K/AKT and JNK signaling pathways].
Zhu S; Yu W; Bi L; Qin F; Li J; Zeng H; Lu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Aug; 38(8):714-720. PubMed ID: 35851085
[TBL] [Abstract][Full Text] [Related]
17. Apelin-13 upregulates Egr-1 expression in rat vascular smooth muscle cells through the PI3K/Akt and PKC signaling pathways.
Liu QF; Yu HW; Sun LL; You L; Tao GZ; Qu BZ
Biochem Biophys Res Commun; 2015 Dec; 468(4):617-21. PubMed ID: 26546817
[TBL] [Abstract][Full Text] [Related]
18. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel induces apoptosis in leukemia cells through a JNK activation-dependent pathway.
Peng ZG; Liu DC; Yao YB; Feng XL; Huang X; Tang YL; Yang J; Wang XX
Genet Mol Res; 2016 Mar; 15(1):15013904. PubMed ID: 26985944
[TBL] [Abstract][Full Text] [Related]
20. TNF-α Increases IP-10 Expression in MCF-7 Breast Cancer Cells via Activation of the JNK/c-Jun Pathways.
Kochumon S; Al-Sayyar A; Jacob T; Hasan A; Al-Mulla F; Sindhu S; Ahmad R
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
